Home / Inspections / 1111164

FDA Inspection 1111164 — Martin Neil Reaume, MD

Martin Neil Reaume, MD — FEI 3015602595

The FDA completed an inspection of Martin Neil Reaume, MD on Nov 15, 2019 in Ottawa. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.

Inspection Details

Classification
No Action Indicated (NAI)
End Date
Nov 15, 2019
Fiscal Year
2020
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Ottawa (Canada)

Additional Details

Clinical Investigator (CI)

Facility

Other inspections at this facility

FDA data resources

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.